Preliminary results of a randomized phase II trial of first-line treatment of gemcitabine (G) versus erlotinib (E) versus gemcitabine and erlotinib (GE) in patients 70 years or older with advanced non-small cell lung cancer (NSCLC).
Year: 2010
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: T. Stinchcombe, D. S. Bradford, C. B. Lee, D. T. Moore, K. M. Bakri, M. A. Taylor, J. M. Crane, G. Schwartz, T. A. Hensing, M. A. Socinski
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2247471946